Extendicare Inc.

TSX:EXE.TO

Medical - Care Facilities

Healthcare
$28.81 +2.61%

+$0.86 today

Market cap
$2.74B
Beta
1.16
P/E (TTM)
26.4
EPS (TTM)
$1.28
Dividend yield
1.51%
52W Low $12.12High $35.62

Volume 0.86M

Average 0.34M

EXE.TO EBITDA Margin

EBITDA as a percentage of revenue.

Extendicare Inc.TSX: EXE.TO

EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026

EBITDA Margin narrows to 10.3%

EBITDA Margin was 10.3% in Q2 FY2026, down 3.9 pp from a year earlier. On a trailing-twelve-month basis it was 10.8%, down 0.2 pp year over year. Over 3 fiscal years it widened by 6.5 pp.

Context

  • EBITDA Margin widened in 2 of the last 3 fiscal years.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 5 analysts of 12.4% for the fiscal year ending Dec 2026, up from 10.6% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
10.3%-1.1 pp QoQ
Last fiscal yearDec 2025
10.6%-0.0 pp YoY
LTMJun 2026
10.8%-0.2 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-3.9 pp+1.6 pp+5.5 pp
1 year-0.0 pp+1.8 pp+1.8 pp
3 years+6.5 pp+3.2 pp-3.4 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
10.6%
Year-over-year change
-0.0pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How EXE.TO compares with its peers on the latest reported figures

  • EXE.TO's LTM Jun 2026 EBITDA Margin of 10.8% is the 5th highest of the 7 companies compared; the peer median is 16.6%.
  • Its year-over-year change of -0.2 pp is the 5th highest of 7, against a peer median of +2.4 pp.
  • Over three fiscal years its change of +6.5 pp compares with a peer median of +5.1 pp.
EXE.TO Competitors Peer median
EBITDA Margin for EXE.TO and competitors
Company Period LTM level YoY 3-year change
CRON.TOCronos Group Inc.LTM Mar 202630.0% +45.0 pp+105.2 pp
DR.TOMedical Facilities CorporationLTM Mar 202624.7% -1.0 pp+10.9 pp
SIA.TOSienna Senior Living Inc.LTM Sep 202618.3% +3.3 pp+1.9 pp
WELL.TOWELL Health Technologies Corp.LTM Mar 202614.9% +8.6 pp-1.9 pp
EXE.TOExtendicare Inc.LTM Jun 202610.8% -0.2 pp+6.5 pp
CRRX.TOCareRx CorporationLTM Mar 20268.0% +1.5 pp+8.3 pp
TLRY.TOTilray Brands, Inc.LTM Feb 2026-156.2% -77.8 pp-219.8 pp
Peer median (excluding EXE.TO) 16.6%+2.4 pp+5.1 pp

Competitors are the stored peer set for EXE.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.17B1.22B1.3B1.47B1.66B
Cost of Revenue1.05B1.14B1.14B1.3B1.46B
Gross Profit115.61M76.83M167.62M168M199.59M
Gross Margin9.9%6.3%12.8%11.5%12.0%
Research & Development00000
Selling, General & Admin69.79M51.08M55.84M1.2B1.36B
Operating Expenses52.43M50.78M55.84M56.94M61.22M
Depreciation & Amortization38.57M32.12M32.23M33.34M37.25M
EBITDA75M49.33M98.63M155.27M175.61M
EBITDA Margin6.4%4.0%7.6%10.6%10.6%
Operating Income49.71M20.99M62.96M111.21M138.37M
Operating Margin4.3%1.7%4.8%7.6%8.3%
Interest Income1.87M5.02M6.19M7.04M5.73M
Interest Expense22.45M21.7M21.6M21.1M19.23M
Other Income / Expenses(35.72M)(25.48M)(18.16M)(11.35M)(8.26M)
Income Before Tax13.99M(4.5M)44.8M99.86M130.1M
Pre-Tax Margin1.2%-0.4%3.4%6.8%7.8%
Income Tax Expense6.48M15K10.82M24.65M33.45M
Net Income11.5M69.55M33.98M75.21M96.66M
Net Margin1.0%5.7%2.6%5.1%5.8%
EPS (Basic)0.130.850.400.971.13
EPS (Diluted)0.130.850.400.861.11
Weighted Avg Shares89.99M89.01M84.99M84.22M85.4M
Weighted Avg Shares (Diluted)100.9M89.01M84.99M95.36M86.84M

Extendicare Inc.

TSX:EXE.TO

Intrinsic Alpha fair value

Locked

Current Price

$28.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.